Lmr Partners LLP Moderna, Inc. Transaction History

Lmr Partners LLP

$10.5 Billion
Q2 2025

A detailed history of Lmr Partners LLP transactions in Moderna, Inc. stock. As of the latest transaction made, Lmr Partners LLP holds 51,400 shares of MRNA stock, worth $1.41 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

51,400

Previous 90,200 43.02%

Holding current value

$1.41 Million

Previous $2.56 Million 44.54%

% of portfolio

0.01%

Previous 0.03%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$23.65 - $28.54 $977,998 - $1.18 Million	41,353 Added 362.75%	52,753 $1.46 Million
Q1 2025 May 15, 2025	BUY	$28.35 - $47.53 $323,190 - $541,842	11,400 New	11,400 $323,000
Q3 2024 Nov 07, 2024	BUY	$63.64 - $125.14 $18.9 Million - $37.1 Million	296,232 Added 549.59%	350,133 $23.4 Million
Q2 2024 Aug 14, 2024	BUY	$101.21 - $166.61 $5.46 Million - $8.98 Million	53,901 New	53,901 $6.4 Million
Q2 2022 Aug 15, 2022	SELL	$117.13 - $176.59 $3.68 Million - $5.56 Million	-31,459 Reduced 40.7%	45,844 $6.55 Million
Q1 2022 May 16, 2022	BUY	$126.46 - $235.05 $9.78 Million - $18.2 Million	77,303 New	77,303 $13.3 Million
Q2 2021 Aug 16, 2021	SELL	$129.91 - $234.98 $4.56 Million - $8.25 Million	-35,100 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$109.18 - $185.98 $8.3 Million - $14.1 Million	-75,996 Reduced 68.41%	35,100 $4.6 Million
Q4 2020 Feb 16, 2021	SELL	$65.74 - $169.86 $13.1 Million - $33.8 Million	-198,746 Reduced 64.14%	111,096 $11.6 Million
Q3 2020 Nov 16, 2020	BUY	$54.34 - $94.85 $16.8 Million - $29.4 Million	309,842 New	309,842 $21.2 Million

Others Institutions Holding MRNA

# of Institutions

861

Shares Held

266M

Call Options Held

28.5M

Put Options Held

34.8M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $10.8B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lmr Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Lmr Partners LLP with notifications on news.

Account